D. Tural Et Al. , "Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6, 2021
Tural, D. Et Al. 2021. Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6 .
Tural, D., Olmez, O. F., Sumbul, A. T., Artac, M., Ozhan, N., Akar, E., ... Cakar, B.(2021). Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6.
Tural, Deniz Et Al. "Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6, 2021
Tural, Deniz Et Al. "Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6, 2021
Tural, D. Et Al. (2021) . "Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.6.
@article{article, author={Deniz Tural Et Al. }, title={Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2021}